The US FDA has finally issued emergency authorization for the first COVID-19 vaccines to be distributed in the country. Here are the important things that you should know.
The FDA approved the emergency use of the COVID-19 vaccine that Pfizer and BioNTech produced. Federal officials finally approved the emergency use of the COVID-19 vaccine that Pfizer and BioNTech produced in a breakthrough decision that commits to drastically alter the fight against COVID-19 in the United States.
On Thursday, the FDA Vaccines Committee recommended the approval for the emergency use of Pfizer's COVID-19 vaccine, which would generate a massive distribution initiative.
This raises the prospect of immunizations in the UK starting weeks ahead of the rest of Europe. Britain is expected to be the pioneering western country to authorize a COVID-19 vaccine, raising the prospect of immunizations starting weeks ahead of the rest of Europe.
If the experimental coronavirus vaccines win approval from the Food and Drug Administration, they will be the first-ever authorized vaccines that use mRNA.
Side effects from vaccines cannot be avoided; experts remind the public. Whenever companies announce the updates on their coronavirus vaccine candidates, they typically mention that some participants experience mild side effects.
Cambridge immunologist Claire Bryant joins BBC's The Naked Scientist podcast to discuss the Pfizer and BioNTech vaccine candidate. Bryant answers key questions about the vaccine technology, side effects, and probable availability.
Even with the side effects, the volunteers said he is confident of the vaccine's safety. Just recently, Pfizer, Inc. announced more than 90 percent efficacy of its COVID-19 vaccine.
The ultra-cold storage might prove to be the vaccine's biggest hurdle yet. Pfizer Inc and BioNTech SE face another dynamic problem as they are heading towards making safe and efficient COVID-19 vaccines.
American drug companies Moderna and Pfizer have disclosed its secret blueprints in their respective coronavirus disease (COVID-19) vaccine trials in a move to gain the confidence of the clamoring public and scientific communities.
Pharmaceutical giant Pfizer has signed a multi-year deal with Gilead Sciences Inc., to boost the production of its investigational antiviral remdesivir, a potential drug against COVID-19.
The deal stated that the 100 million doses of coronavirus vaccine is free to Americans, although health care providers could charge for administration. The deal would also allow the federal government to acquire an additional 500 million doses of the Pfizer vaccine.
In the last day of ASCO 2017 annual meeting on Tuesday, researchers presented the data of Dacomitinib that delayed the growth of the lung cancer longer than Gefitinib, trademarked as Iressa in newly diagnosed patients.
A new study released contradicted previous claim that the stop-smoking drug of Pfizer causes an increase risk of heart attacks and depression to users.
The long wait for Pfizer over the pending acquisition for Hospira is finally over. Pfizer, one of the biggest American pharmaceutical corporations, finally obtained the approval from the U.
In light of promising results conducted by an independent data monitoring committee, Pfizer’s newest treatment IBRANCE (Palbociclib) ended clinical trials early this week as phase 3 of the trials ended demonstrating improvement in progression-free survival in women who had undergone treatment for metastatic breast cancer.
Chantix has helped many people quit smoking in the years since its release. However, on Monday the U.S. Food and Drug Administration issued a warning about the quit-smoking drug made by Pfizer Inc. According to the FDA, the drug has been associated with seizures and that some patients who drink while taking the drug may become aggressive or even black out.